In clinical trials, Wegovy was shown to reduce body weight in people with body mass indexes, or BMIs, of 27 or greater by around 15% over 68 weeks
Well, berberine boosts GLP-1 secretion in rats and petri dishes, but there havent been any GLP-1 studies on humans yet
We asked three experts, and all three brought up this one benefit: Some individuals on semaglutide or tirzepatide report less interest in alcohol, says Dr
B-Complex shot supports energy, metabolism, and overall wellness with B vitamins
A study by Mass Eye and Ear (which was published in JAMA Ophthalmology) found that those on semaglutide were four times more likely to develop NAION (17 of 200 diabetes patients) and seven times more likely to develop NAION if they were also obese or overweight (20 of 361 overweight or obese patients)
The Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT) study was a randomized controlled trial, conducted by Novo Nordisk, which looked at rates of cardiovascular events in people who already had known heart risk and were overweight, but not diabetic
